Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Liver Diseases

  Free Subscription

Articles published in Oncogene

Retrieve available abstracts of 65 articles:
HTML format

Single Articles

    November 2022
  1. ZHENG M, Ai Z, Guo Y, Chen Y, et al
    Imbalance in ALR ubiquitination accelerates the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma.
    Oncogene. 2022 Nov 25. doi: 10.1038/s41388-022-02549.
    PubMed     Abstract available

  2. JIN C, Han-Hua D, Qiu-Meng L, Deng N, et al
    MTDH-stabilized DDX17 promotes tumor initiation and progression through interacting with YB1 to induce EGFR transcription in Hepatocellular Carcinoma.
    Oncogene. 2022 Nov 17. pii: 10.1038/s41388-022-02545.
    PubMed     Abstract available

  3. ZHANG H, Liao Z, Wang W, Liu Y, et al
    A micropeptide JunBP regulated by TGF-beta promotes hepatocellular carcinoma metastasis.
    Oncogene. 2022 Nov 15. pii: 10.1038/s41388-022-02518.
    PubMed     Abstract available

  4. MA M, Zhang C, Cao R, Tang D, et al
    UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination.
    Oncogene. 2022;41:5199-5213.
    PubMed     Abstract available

    October 2022
  5. WANG X, Liu Y, Han A, Tang C, et al
    The NQO1/p53/SREBP1 axis promotes hepatocellular carcinoma progression and metastasis by regulating Snail stability.
    Oncogene. 2022 Oct 17. pii: 10.1038/s41388-022-02477.
    PubMed     Abstract available

    September 2022
  6. LI T, Xie J, Shen C, Cheng D, et al
    Retraction Note: Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma.
    Oncogene. 2022 Sep 30. pii: 10.1038/s41388-022-02480.

  7. CHAND V, Liao X, Guzman G, Benevolenskaya E, et al
    Correction: Hepatocellular carcinoma evades RB1-induced senescence by activating the FOXM1-FOXO1 axis.
    Oncogene. 2022 Sep 7. pii: 10.1038/s41388-022-02436.

  8. DISKIN B, Adam S, Soto GS, Liria M, et al
    BTLA(+)CD200(+) B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer.
    Oncogene. 2022;41:4349-4360.
    PubMed     Abstract available

    August 2022
  9. GAO M, Qi Z, Deng M, Huang H, et al
    The deubiquitinase USP7 regulates oxidative stress through stabilization of HO-1.
    Oncogene. 2022;41:4018-4027.
    PubMed     Abstract available

    July 2022
  10. DOU C, Zhou Z, Xu Q, Liu Z, et al
    Correction: Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca(2+)/PI3K/AKT pathway.
    Oncogene. 2022 Jul 27. pii: 10.1038/s41388-022-02421.

  11. DONG P, Cai Z, Li B, Zhu Y, et al
    HFE promotes mitotic cell division through recruitment of cytokinetic abscission machinery in hepatocellular carcinoma.
    Oncogene. 2022 Jul 26. pii: 10.1038/s41388-022-02419.
    PubMed     Abstract available

  12. YING C, Jin C, Zeng S, Chao M, et al
    Alkalization of cellular pH leads to cancer cell death by disrupting autophagy and mitochondrial function.
    Oncogene. 2022;41:3886-3897.
    PubMed     Abstract available

    June 2022
  13. PAN D, Yang W, Zeng Y, Qin H, et al
    AKR1C3 regulated by NRF2/MAFG complex promotes proliferation via stabilizing PARP1 in hepatocellular carcinoma.
    Oncogene. 2022 Jun 30. pii: 10.1038/s41388-022-02379.
    PubMed     Abstract available

  14. CHAND V, Liao X, Guzman G, Benevolenskaya E, et al
    Hepatocellular carcinoma evades RB1-induced senescence by activating the FOXM1-FOXO1 axis.
    Oncogene. 2022 Jun 27. pii: 10.1038/s41388-022-02394.
    PubMed     Abstract available

  15. WANG Y, Zhang Y, Mi J, Jiang C, et al
    ANKFN1 plays both protumorigenic and metastatic roles in hepatocellular carcinoma.
    Oncogene. 2022 Jun 21. pii: 10.1038/s41388-022-02380.
    PubMed     Abstract available

  16. MA XL, Zhu KY, Chen YD, Tang WG, et al
    Identification of a novel Calpain-2-SRC feed-back loop as necessity for beta-Catenin accumulation and signaling activation in hepatocellular carcinoma.
    Oncogene. 2022 Jun 13. pii: 10.1038/s41388-022-02367.
    PubMed     Abstract available

  17. LIU Y, Ouyang L, Mao C, Chen Y, et al
    PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma.
    Oncogene. 2022 Jun 10. pii: 10.1038/s41388-022-02370.
    PubMed     Abstract available

    May 2022
  18. CHEN S, Cheng J, Zhong Y, Liu R, et al
    Correction: Liver-specific overexpression of Gab2 accelerates hepatocellular carcinoma progression by activating immunosuppression of myeloid-derived suppressor cells.
    Oncogene. 2022 May 6. pii: 10.1038/s41388-022-02337.

    April 2022
  19. LI K, Niu Y, Yuan Y, Qiu J, et al
    Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-beta signaling.
    Oncogene. 2022 Apr 30. pii: 10.1038/s41388-022-02334.
    PubMed     Abstract available

  20. CHEN J, Li Z, Jia X, Song W, et al
    Targeting anillin inhibits tumorigenesis and tumor growth in hepatocellular carcinoma via impairing cytokinesis fidelity.
    Oncogene. 2022 Apr 27. pii: 10.1038/s41388-022-02274.
    PubMed     Abstract available

  21. TSAI YT, Li CY, Huang YH, Chang TS, et al
    Galectin-1 orchestrates an inflammatory tumor-stroma crosstalk in hepatoma by enhancing TNFR1 protein stability and signaling in carcinoma-associated fibroblasts.
    Oncogene. 2022 Apr 22. pii: 10.1038/s41388-022-02309.
    PubMed     Abstract available

  22. HOCHNADEL I, Hoenicke L, Petriv N, Neubert L, et al
    Correction: Safety and efficacy of prophylactic and therapeutic vaccine based on live-attenuated Listeria monocytogenes in hepatobiliary cancers.
    Oncogene. 2022 Apr 13. pii: 10.1038/s41388-022-02261.

  23. CHEN S, Cheng J, Zhong Y, Liu R, et al
    Liver-specific overexpression of Gab2 accelerates hepatocellular carcinoma progression by activating immunosuppression of myeloid-derived suppressor cells.
    Oncogene. 2022 Apr 11. pii: 10.1038/s41388-022-02298.
    PubMed     Abstract available

    March 2022
  24. CHEN X, Wang Z, Zhao X, Zhang L, et al
    STAT5A modulates CDYL2/SLC7A6 pathway to inhibit the proliferation and invasion of hepatocellular carcinoma by targeting to mTORC1.
    Oncogene. 2022 Mar 21. pii: 10.1038/s41388-022-02273.
    PubMed     Abstract available

  25. GU Y, Guo Y, Gao N, Fang Y, et al
    The proteomic characterization of the peritumor microenvironment in human hepatocellular carcinoma.
    Oncogene. 2022 Mar 21. pii: 10.1038/s41388-022-02264.
    PubMed     Abstract available

  26. WU WR, Shi XD, Zhang FP, Zhu K, et al
    Activation of the Notch1-c-myc-VCAM1 signalling axis initiates liver progenitor cell-driven hepatocarcinogenesis and pulmonary metastasis.
    Oncogene. 2022 Mar 7. pii: 10.1038/s41388-022-02246.
    PubMed     Abstract available

  27. LV B, Pan Y, Hou D, Chen P, et al
    RNF4 silencing induces cell growth arrest and DNA damage by promoting nuclear targeting of p62 in hepatocellular carcinoma.
    Oncogene. 2022 Mar 2. pii: 10.1038/s41388-022-02247.
    PubMed     Abstract available

  28. HAN L, Lin X, Yan Q, Gu C, et al
    PBLD inhibits angiogenesis via impeding VEGF/VEGFR2-mediated microenvironmental cross-talk between HCC cells and endothelial cells.
    Oncogene. 2022;41:1851-1865.
    PubMed     Abstract available

  29. RAO VS, Gu Q, Tzschentke S, Lin K, et al
    Extravesicular TIMP-1 is a non-invasive independent prognostic marker and potential therapeutic target in colorectal liver metastases.
    Oncogene. 2022;41:1809-1820.
    PubMed     Abstract available

  30. JOURNO S, Goldberg AK, Sokol ES, Zinger L, et al
    Genomic alterations drive metastases formation in pancreatic ductal adenocarcinoma cancer: deciphering the role of CDKN2A and CDKN2B in mediating liver tropism.
    Oncogene. 2022;41:1468-1481.
    PubMed     Abstract available

    February 2022
  31. JI X, Chen X, Zhang B, Xie M, et al
    T-box transcription factor 19 promotes hepatocellular carcinoma metastasis through upregulating EGFR and RAC1.
    Oncogene. 2022 Feb 26. pii: 10.1038/s41388-022-02249.
    PubMed     Abstract available

  32. HOCHNADEL I, Hoenicke L, Petriv N, Neubert L, et al
    Safety and efficacy of prophylactic and therapeutic vaccine based on live-attenuated Listeria monocytogenes in hepatobiliary cancers.
    Oncogene. 2022 Feb 16. pii: 10.1038/s41388-022-02222.
    PubMed     Abstract available

  33. LI B, Kang H, Xiao Y, Du Y, et al
    LncRNA GAL promotes colorectal cancer liver metastasis through stabilizing GLUT1.
    Oncogene. 2022 Feb 11. pii: 10.1038/s41388-022-02230.
    PubMed     Abstract available

  34. ZHANG X, Hu Y, Pan Y, Xiong Y, et al
    DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6.
    Oncogene. 2022 Feb 9. pii: 10.1038/s41388-022-02212.
    PubMed     Abstract available

  35. DESI N, Teh V, Tong QY, Lim CY, et al
    MiR-138 is a potent regulator of the heterogenous MYC transcript population in cancers.
    Oncogene. 2022;41:1178-1189.
    PubMed     Abstract available

    January 2022
  36. XU QC, Tien YC, Shi YH, Chen S, et al
    METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m(6)A-YTHDF2-dependent manner.
    Oncogene. 2022 Jan 29. pii: 10.1038/s41388-022-02185.
    PubMed     Abstract available

  37. CHIAVARINA B, Ronca R, Otaka Y, Sutton RB, et al
    Fibroblast-derived prolargin is a tumor suppressor in hepatocellular carcinoma.
    Oncogene. 2022 Jan 14. pii: 10.1038/s41388-021-02171.
    PubMed     Abstract available

  38. HE DD, Shang XY, Wang N, Wang GX, et al
    BRD4 inhibition induces synthetic lethality in ARID2-deficient hepatocellular carcinoma by increasing DNA damage.
    Oncogene. 2022 Jan 11. pii: 10.1038/s41388-022-02176.
    PubMed     Abstract available

    December 2021
  39. LIU R, Gou D, Xiang J, Pan X, et al
    O-GlcNAc modified-TIP60/KAT5 is required for PCK1 deficiency-induced HCC metastasis.
    Oncogene. 2021;40:6707-6719.
    PubMed     Abstract available

    November 2021
  40. SUN L, Xi S, Zhou Z, Zhang F, et al
    Elevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitor.
    Oncogene. 2021 Nov 29. pii: 10.1038/s41388-021-02130.
    PubMed     Abstract available

  41. GILL T, Wang H, Bandaru R, Lawlor M, et al
    Selective targeting of MYC mRNA by stabilized antisense oligonucleotides.
    Oncogene. 2021;40:6527-6539.
    PubMed     Abstract available

    September 2021
  42. LI B, Xia Y, Lv J, Wang W, et al
    miR-151a-3p-rich small extracellular vesicles derived from gastric cancer accelerate liver metastasis via initiating a hepatic stemness-enhancing niche.
    Oncogene. 2021 Sep 17. pii: 10.1038/s41388-021-02011.
    PubMed     Abstract available

  43. LU L, Zhang J, Fan W, Li Y, et al
    Deregulated 14-3-3zeta and methionine adenosyltransferase alpha1 interplay promotes liver cancer tumorigenesis in mice and humans.
    Oncogene. 2021;40:5866-5879.
    PubMed     Abstract available

  44. ZHANG X, Dou P, Akhtar ML, Liu F, et al
    NEU4 inhibits motility of HCC cells by cleaving sialic acids on CD44.
    Oncogene. 2021;40:5427-5440.
    PubMed     Abstract available

    August 2021
  45. QIU P, Hou W, Wang H, Lei KKW, et al
    Sirt1 deficiency upregulates glutathione metabolism to prevent hepatocellular carcinoma initiation in mice.
    Oncogene. 2021 Aug 25. pii: 10.1038/s41388-021-01993.
    PubMed     Abstract available

  46. SHERMAN J, Verstandig G, Brumer Y
    Application of machine learning to large in-vitro databases to identify cancer cell characteristics: telomerase reverse transcriptase (TERT) expression.
    Oncogene. 2021;40:5038-5041.
    PubMed     Abstract available

    July 2021
  47. LIU Z, Wang A, Pu Y, Li Z, et al
    Genomic and transcriptomic profiling of hepatoid adenocarcinoma of the stomach.
    Oncogene. 2021 Jul 30. pii: 10.1038/s41388-021-01976.
    PubMed     Abstract available

  48. ZHANG Y, Yan Q, Gong L, Xu H, et al
    Correction: C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism.
    Oncogene. 2021 Jul 26. pii: 10.1038/s41388-021-01942.

  49. BRAHMA MK, Gilglioni EH, Zhou L, Trepo E, et al
    Oxidative stress in obesity-associated hepatocellular carcinoma: sources, signaling and therapeutic challenges.
    Oncogene. 2021 Jul 21. pii: 10.1038/s41388-021-01950.
    PubMed     Abstract available

  50. ZHANG EB, Zhang X, Wang K, Zhang F, et al
    Antifungal agent Terbinafine restrains tumor growth in preclinical models of hepatocellular carcinoma via AMPK-mTOR axis.
    Oncogene. 2021 Jul 10. pii: 10.1038/s41388-021-01934.
    PubMed     Abstract available

  51. XU F, Jiang L, Zhao Q, Zhang Z, et al
    Whole-transcriptome and proteome analyses identify key differentially expressed mRNAs, miRNAs, lncRNAs and circRNAs associated with HCC.
    Oncogene. 2021;40:4820-4831.
    PubMed     Abstract available

    June 2021
  52. ZHAO S, Guan B, Mi Y, Shi D, et al
    LncRNA MIR17HG promotes colorectal cancer liver metastasis by mediating a glycolysis-associated positive feedback circuit.
    Oncogene. 2021 Jun 18. pii: 10.1038/s41388-021-01859.
    PubMed     Abstract available

  53. LIN YH, Wu MH, Liu YC, Lyu PC, et al
    LINC01348 suppresses hepatocellular carcinoma metastasis through inhibition of SF3B3-mediated EZH2 pre-mRNA splicing.
    Oncogene. 2021 Jun 17. pii: 10.1038/s41388-021-01905.
    PubMed     Abstract available

  54. WANG S, Cao K, Liao Y, Zhang W, et al
    CDCA2 protects against oxidative stress by promoting BRCA1-NRF2 signaling in hepatocellular carcinoma.
    Oncogene. 2021 Jun 8. pii: 10.1038/s41388-021-01855.
    PubMed     Abstract available

  55. WANG X, Dong J, Li X, Cheng Z, et al
    CPSF4 regulates circRNA formation and microRNA mediated gene silencing in hepatocellular carcinoma.
    Oncogene. 2021 Jun 8. pii: 10.1038/s41388-021-01867.
    PubMed     Abstract available

  56. SHEN M, Zhang R, Jia W, Zhu Z, et al
    Nuclear scaffold protein p54(nrb)/NONO facilitates the hypoxia-enhanced progression of hepatocellular carcinoma.
    Oncogene. 2021 Jun 2. pii: 10.1038/s41388-021-01848.
    PubMed     Abstract available

  57. WANG Y, Yu H, Xie X, Deng T, et al
    Plasmalemma vesicle-associated protein promotes angiogenesis in cholangiocarcinoma via the DKK1/CKAP4/PI3K signaling pathway.
    Oncogene. 2021;40:4324-4337.
    PubMed     Abstract available

    May 2021
  58. CAROTTI S, Zingariello M, Francesconi M, D'Andrea L, et al
    Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge.
    Oncogene. 2021 May 20. pii: 10.1038/s41388-021-01824.
    PubMed     Abstract available

  59. ZHANG XL, Hu LP, Yang Q, Qin WT, et al
    CTHRC1 promotes liver metastasis by reshaping infiltrated macrophages through physical interactions with TGF-beta receptors in colorectal cancer.
    Oncogene. 2021 May 13. pii: 10.1038/s41388-021-01827.
    PubMed     Abstract available

    April 2021
  60. CHEN S, Du Y, Xu B, Li Q, et al
    Vaccinia-related kinase 2 blunts sorafenib's efficacy against hepatocellular carcinoma by disturbing the apoptosis-autophagy balance.
    Oncogene. 2021 Apr 19. pii: 10.1038/s41388-021-01780.
    PubMed     Abstract available

  61. CHEN K, Hou Y, Liao R, Li Y, et al
    LncRNA SNHG6 promotes G1/S-phase transition in hepatocellular carcinoma by impairing miR-204-5p-mediated inhibition of E2F1.
    Oncogene. 2021 Apr 6. pii: 10.1038/s41388-021-01671.
    PubMed     Abstract available

  62. LAO M, Zhang X, Ma T, Xu J, et al
    Regulator of calcineurin 1 gene isoform 4 in pancreatic ductal adenocarcinoma regulates the progression of tumor cells.
    Oncogene. 2021;40:3136-3151.
    PubMed     Abstract available

  63. PAN Z, Liu C, Zhi Y, Xie Z, et al
    LIMK1 nuclear translocation promotes hepatocellular carcinoma progression by increasing p-ERK nuclear shuttling and by activating c-Myc signalling upon EGF stimulation.
    Oncogene. 2021;40:2581-2595.
    PubMed     Abstract available

    February 2021
  64. LUO JH, Liu S, Tao J, Ren BG, et al
    Pten-NOLC1 fusion promotes cancers involving MET and EGFR signalings.
    Oncogene. 2021;40:1064-1076.
    PubMed     Abstract available

    October 2020
  65. NIMMAKAYALA RK, Leon F, Rachagani S, Rauth S, et al
    Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
    Oncogene. 2020 Oct 27. pii: 10.1038/s41388-020-01518.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.